Business Wire | Feb 18, 2021 04:15PM EST

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Feb. 18, 2021

BRISBANE, Calif.--(BUSINESS WIRE)--Feb. 18, 2021--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

* Cowen 41st Annual Health Care Conference Date: Monday, March 1st at 2:40 p.m. Eastern Time

* H.C. Wainwright Global Life Sciences Conference Date: Tuesday, March 9th at 7:00 a.m. Eastern Time

* Barclays Global Healthcare Conference Date: Wednesday, March 10th at 10:55 a.m. Eastern Time

For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005058/en/

CONTACT: Investor Relations & Media Inquiries Aron Feingold 628.252.7494 afeingold@sangamo.com